Drug release from coronary eluting stents: A multidomain approach.

[1]  Rosaire Mongrain,et al.  Numerical modeling of coronary drug eluting stents. , 2005, Studies in health technology and informatics.

[2]  A. Furber,et al.  Coronary Blood Flow Assessment After Successful Angioplasty for Acute Myocardial Infarction Predicts the Risk of Long-Term Cardiac Events , 2004, Circulation.

[3]  E. Edelman,et al.  Carrier proteins determine local pharmacokinetics and arterial distribution of paclitaxel. , 2001, Journal of pharmaceutical sciences.

[4]  Elazer R Edelman,et al.  Intravascular drug release kinetics dictate arterial drug deposition, retention, and distribution. , 2007, Journal of controlled release : official journal of the Controlled Release Society.

[5]  Rossella Fattori,et al.  Drug-eluting stents in vascular intervention , 2003, The Lancet.

[6]  A. Tzafriri,et al.  Strut Position, Blood Flow, and Drug Deposition: Implications for Single and Overlapping Drug-Eluting Stents , 2005, Circulation.

[7]  Giuseppe Pontrelli,et al.  Novel design of drug delivery in stented arteries: a numerical comparative study. , 2009, Mathematical biosciences and engineering : MBE.

[8]  Giuseppe Pontrelli,et al.  Mass diffusion through two-layer porous media: an application to the drug-eluting stent , 2007 .

[9]  Timothy A. Davis,et al.  Algorithm 837: AMD, an approximate minimum degree ordering algorithm , 2004, TOMS.

[10]  J. Nawarskas,et al.  The Paclitaxel-Eluting Stent in Percutaneous Coronary Intervention: Part I: Background and Clinical Comparison to Bare Metal Stents , 2006, Cardiology in review.

[11]  Marvin J. Slepian,et al.  Polymeric endoluminal gel paving: hydrogel systems for local barrier creation and site-specific drug delivery , 1997 .

[12]  P. Deuflhard.  A modified Newton method for the solution of ill-conditioned systems of nonlinear equations with application to multiple shooting , 1974 .

[13]  E. Edelman,et al.  Specific binding to intracellular proteins determines arterial transport properties for rapamycin and paclitaxel. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[14]  T. Higuchi,et al.  Rate of release of medicaments from ointment bases containing drugs in suspension. , 1961, Journal of pharmaceutical sciences.

[15]  K Perktold,et al.  Effect of endothelial injury and increased blood pressure on albumin accumulation in the arterial wall: a numerical study. , 2000, Journal of biomechanics.

[16]  H. Schlichting.  Boundary Layer Theory , 1955 .

[17]  Frank Litvack,et al.  Local Drug Delivery via a Coronary Stent With Programmable Release Pharmacokinetics , 2003, Circulation.

[18]  A. Katchalsky,et al.  Thermodynamic analysis of the permeability of biological membranes to non-electrolytes. , 1958, Biochimica et biophysica acta.

[19]  Alfio Quarteroni,et al.  Domain Decomposition Methods for Partial Differential Equations , 1999 .

[20]  Chia-Ven Pao,et al.  Nonlinear parabolic and elliptic equations , 1993 .

[21]  Muzaffer Degertekin,et al.  TAXUS III Trial: In-Stent Restenosis Treated With Stent-Based Delivery of Paclitaxel Incorporated in a Slow-Release Polymer Formulation , 2003, Circulation.

[22]  Francesco Migliavacca,et al.  Effects of different stent designs on local hemodynamics in stented arteries. , 2008, Journal of biomechanics.

[23]  Timothy A. Davis,et al.  A column approximate minimum degree ordering algorithm , 2000, TOMS.

[24]  E. Edelman,et al.  Physiological Transport Forces Govern Drug Distribution for Stent-Based Delivery , 2001, Circulation.

[25]  J. Humphrey,et al.  Open Problems in Computational Vascular Biomechanics: Hemodynamics and Arterial Wall Mechanics. , 2009, Computer methods in applied mechanics and engineering.

[26]  CHRISTIAN VERGARA,et al.  Multiscale Boundary Conditions for Drug Release from Cardiovascular Stents , 2008, Multiscale Model. Simul..

[27]  E. Edelman,et al.  Arterial paclitaxel distribution and deposition. , 2000, Circulation research.

[28]  L. Kalachev,et al.  Numerical Simulation of Local Pharmacokinetics of a Drug after Intravascular Delivery with an Eluting Stent , 2002, Journal of drug targeting.

[29]  P Zunino,et al.  Expansion and drug elution model of a coronary stent , 2007, Computer methods in biomechanics and biomedical engineering.

[30]  A. Friedman.  Partial Differential Equations of Parabolic Type , 1983 .

[31]  A. Tedgui,et al.  Effects of pressure-induced stretch and convection on low-density lipoprotein and albumin uptake in the rabbit aortic wall. , 1996, Circulation research.

[32]  S. Przestalski,et al.  The Kedem-Katchalsky equations as applied for describing substance transport across biological membranes , 1997 .

[33]  D R Hose,et al.  A Thermal Analogy for Modelling Drug Elution from Cardiovascular Stents , 2004, Computer methods in biomechanics and biomedical engineering.

[34]  Patrick R. Amestoy,et al.  An Approximate Minimum Degree Ordering Algorithm , 1996, SIAM J. Matrix Anal. Appl..

[35]  W. Wijns.  Incidence of stent under-deployment as a cause of in-stent restenosis in long stents Take your lesson ! , 2004, The International Journal of Cardiovascular Imaging.

[36]  Elazer R Edelman,et al.  Thrombus causes fluctuations in arterial drug delivery from intravascular stents. , 2008, Journal of controlled release : official journal of the Controlled Release Society.

[37]  J Wouter Jukema,et al.  Drug-eluting stents: results, promises and problems. , 2005, International journal of cardiology.

[38]  Paolo Zunino,et al.  Multidimensional Pharmacokinetic Models Applied to the Design of Drug-Eluting Stents , 2004 .

[39]  Elazer R Edelman,et al.  Arterial heparin deposition: role of diffusion, convection, and extravascular space. , 1998, American journal of physiology. Heart and circulatory physiology.

[40]  J. Tardif,et al.  Incidence of Stent Under-Deployment as a Cause of in-Stent Restenosis in Long Stents , 2004, The International Journal of Cardiovascular Imaging.

[41]  E. Edelman,et al.  Computational simulations of local vascular heparin deposition and distribution. , 1996, The American journal of physiology.

[42]  G. Trevi,et al.  Paclitaxel-eluting stents for the treatment of complex coronary lesions: immediate and 12-month results , 2007, Journal of cardiovascular medicine.

[43]  K Perktold,et al.  Mathematical and numerical models for transfer of low-density lipoproteins through the arterial walls: a new methodology for the model set up with applications to the study of disturbed lumenal flow. , 2005, Journal of biomechanics.

[44]  Isam Faik,et al.  Effects of diffusion coefficients and struts apposition using numerical simulations for drug eluting coronary stents. , 2007, Journal of biomechanical engineering.

[45]  G Dubini,et al.  Modelling drug elution from stents: effects of reversible binding in the vascular wall and degradable polymeric matrix , 2008, Computer methods in biomechanics and biomedical engineering.

[46]  F. Maceri,et al.  Un modello del rilascio di farmaco in stent coronarici (in Italian) - a drug release model for coronary eluting stents , 2008 .

[47]  Elazer R Edelman,et al.  Arterial Ultrastructure Influences Transport of Locally Delivered Drugs , 2002, Circulation research.

[48]  H. Burt,et al.  Drug-eluting stents: factors governing local pharmacokinetics. , 2006, Advanced drug delivery reviews.

[49]  Giuseppe Pontrelli,et al.  Mathematical modelling of NABD release from endoluminal gel paved stent , 2009, Comput. Biol. Chem..

[50]  Gerard A Ateshian,et al.  Integrative biomechanics: a paradigm for clinical applications of fundamental mechanics. , 2009, Journal of biomechanics.

[51]  E. Edelman,et al.  Thrombosis Modulates Arterial Drug Distribution for Drug-Eluting Stents , 2005, Circulation.